Tech Company Financing Transactions
Inductive Bio Funding Round
Inductive Bio secured a $4.3 million Seed funding round on 12/13/2023. Investors included a16z crypto, Lux Capital and AlleyCorp.
Transaction Overview
Company Name
Announced On
12/13/2023
Transaction Type
Venture Equity
Amount
$4,300,000
Round
Seed
Investors
a16z crypto (Lead Investor)
Lux Capital (Lead Investor)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
San Francisco, CA Undisclosed
USA
San Francisco, CA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Overview
Developer of a machine learning platform designed to accelerate the compound optimization process. The company's platform specializes in building datasets and ML models to map the drivers of small molecule Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET), enabling scientists to optimize initial compounds into leads and development candidates faster and with a better balance of ADMET properties which helps them develop new therapeutics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Josh Haimson
Chief Technical Officer
Ben Birnbaum
Browse more venture capital transactions:
Prev: 12/13/2023: Season Health venture capital transaction
Next: 12/13/2023: SellersFi venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs